330 related articles for article (PubMed ID: 28663253)
21. Dual role of the p38 MAPK/cPLA2 pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists.
Rukoyatkina N; Mindukshev I; Walter U; Gambaryan S
Cell Death Dis; 2013 Nov; 4(11):e931. PubMed ID: 24263105
[TBL] [Abstract][Full Text] [Related]
22. Thrombin-triggered platelet apoptosis.
Leytin V; Allen DJ; Mykhaylov S; Lyubimov E; Freedman J
J Thromb Haemost; 2006 Dec; 4(12):2656-63. PubMed ID: 16961585
[TBL] [Abstract][Full Text] [Related]
23. Platelet senescence and phosphatidylserine exposure.
Dasgupta SK; Argaiz ER; Mercado JE; Maul HO; Garza J; Enriquez AB; Abdel-Monem H; Prakasam A; Andreeff M; Thiagarajan P
Transfusion; 2010 Oct; 50(10):2167-75. PubMed ID: 20456701
[TBL] [Abstract][Full Text] [Related]
24. High-Dose Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity.
Aliotta A; Bertaggia Calderara D; Zermatten MG; Alberio L
Thromb Haemost; 2021 Oct; 121(10):1337-1344. PubMed ID: 33690868
[TBL] [Abstract][Full Text] [Related]
25. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets.
Schoenwaelder SM; Jarman KE; Gardiner EE; Hua M; Qiao J; White MJ; Josefsson EC; Alwis I; Ono A; Willcox A; Andrews RK; Mason KD; Salem HH; Huang DC; Kile BT; Roberts AW; Jackson SP
Blood; 2011 Aug; 118(6):1663-74. PubMed ID: 21673344
[TBL] [Abstract][Full Text] [Related]
26. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
[TBL] [Abstract][Full Text] [Related]
27. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL
Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis.
Kim SH; Lim KM; Noh JY; Kim K; Kang S; Chang YK; Shin S; Chung JH
Toxicol Sci; 2011 Nov; 124(1):215-24. PubMed ID: 21865289
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of resveratrol-induced platelet apoptosis.
Lin KH; Hsiao G; Shih CM; Chou DS; Sheu JR
Cardiovasc Res; 2009 Aug; 83(3):575-85. PubMed ID: 19423619
[TBL] [Abstract][Full Text] [Related]
30. Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation.
Alberio L; Ravanat C; Hechler B; Mangin PH; Lanza F; Gachet C
Thromb Haemost; 2017 Jun; 117(6):1101-1114. PubMed ID: 28382366
[TBL] [Abstract][Full Text] [Related]
31. Role of mitochondrial permeability transition pore in coated-platelet formation.
Remenyi G; Szasz R; Friese P; Dale GL
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):467-71. PubMed ID: 15591217
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
Rukoyatkina N; Walter U; Friebe A; Gambaryan S
Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
[TBL] [Abstract][Full Text] [Related]
33. Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets.
Unsworth AJ; Bye AP; Tannetta DS; Desborough MJR; Kriek N; Sage T; Allan HE; Crescente M; Yaqoob P; Warner TD; Jones CI; Gibbins JM
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1482-1493. PubMed ID: 28619996
[TBL] [Abstract][Full Text] [Related]
34. Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol.
Södergren AL; Ramström S
Sci Rep; 2018 Jan; 8(1):1441. PubMed ID: 29362366
[TBL] [Abstract][Full Text] [Related]
35. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
36. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity.
Jun EA; Lim KM; Kim K; Bae ON; Noh JY; Chung KH; Chung JH
Nanotoxicology; 2011 Jun; 5(2):157-67. PubMed ID: 20822370
[TBL] [Abstract][Full Text] [Related]
37. Omi/HtrA2 and XIAP are components of platelet apoptosis signalling.
Winkler J; Rand ML; Schmugge M; Speer O
Thromb Haemost; 2013 Mar; 109(3):532-9. PubMed ID: 23306356
[TBL] [Abstract][Full Text] [Related]
38. Apoptotic activity in stored human platelets.
Perrotta PL; Perrotta CL; Snyder EL
Transfusion; 2003 Apr; 43(4):526-35. PubMed ID: 12662287
[TBL] [Abstract][Full Text] [Related]
39. Selective triggering of platelet apoptosis, platelet activation or both.
Gyulkhandanyan AV; Mutlu A; Freedman J; Leytin V
Br J Haematol; 2013 Apr; 161(2):245-54. PubMed ID: 23398569
[TBL] [Abstract][Full Text] [Related]
40. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.
Kim JE; Han M; Hanl KS; Kim HK
Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
